Page last updated: 2024-09-04

cyc 682 and on 01910

cyc 682 has been researched along with on 01910 in 1 studies

Compound Research Comparison

Studies
(cyc 682)
Trials
(cyc 682)
Recent Studies (post-2010)
(cyc 682)
Studies
(on 01910)
Trials
(on 01910)
Recent Studies (post-2010) (on 01910)
30518801369

Protein Interaction Comparison

ProteinTaxonomycyc 682 (IC50)on 01910 (IC50)
Serine/threonine-protein kinase PLK1Homo sapiens (human)0.009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jabbour, E; Kadia, TM; Kantarjian, H1

Reviews

1 review(s) available for cyc 682 and on 01910

ArticleYear
Failure of hypomethylating agent-based therapy in myelodysplastic syndromes.
    Seminars in oncology, 2011, Volume: 38, Issue:5

    Topics: Adenine Nucleotides; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Clofarabine; Cytosine; Decitabine; Drug Resistance; Drug Substitution; Enzyme Inhibitors; Glutathione; Glycine; Humans; Myelodysplastic Syndromes; Stem Cell Transplantation; Sulfones; Treatment Failure

2011